Loading...
•
Dec 31, 2020
OrthoPediatrics Q4 2020 Earnings Report
OrthoPediatrics experienced a slight revenue decrease in Q4 2020 due to a revenue reduction related to a distributor conversion, but saw strong domestic growth and international sales agency growth.
Key Takeaways
OrthoPediatrics reported Q4 2020 revenue of $18.9 million, a 0.1% decrease compared to Q4 2019. The company experienced a $2.7 million revenue reduction due to a distributor conversion in Germany, Austria, and Switzerland. Domestic revenue grew by 26.1%, while international sales agency revenue increased by 51%.
Total revenue for the fourth quarter was $18.9 million, a 0.1% decrease compared to the same period last year.
U.S. revenue increased by 26.1% compared to the prior year.
International revenue decreased by 77.7% compared to the same period last year.
Gross profit margin improved to 79.9%, compared to 76.2% for the same period last year.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics Revenue by Segment
OrthoPediatrics Revenue by Geographic Location
Revenue by Segment
Trauma & Deformity Revenue
CapyFin.comScoliosis Revenue
CapyFin.comSports Medicine/Other Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
For full year 2021, OrthoPediatrics expects sales to reach $93-98 million, representing a range of 31%-38% growth.
Positive Outlook
- Expects domestic growth to continue, approaching pre-COVID levels.
- Expects significant improvement in international sales due to the recovery by stocking distributors and continued sales agency growth, starting in the first quarter of 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income